vs

Side-by-side financial comparison of Empire State Realty Trust, Inc. (ESRT) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $190.3M, roughly 1.2× Empire State Realty Trust, Inc.). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 1.6%, a 4.2% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 5.7%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 0.2%).

Empire State Realty Trust is a leading real estate investment trust that owns, manages, and operates a portfolio of premium commercial, residential, and retail properties primarily in the New York City metropolitan area, including the iconic Empire State Building. It serves corporate tenants, retail partners, and residential occupants, focusing on sustainable property operations and long-term asset value growth.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

ESRT vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.2× larger
UTI
$220.8M
$190.3M
ESRT
Growing faster (revenue YoY)
UTI
UTI
+3.9% gap
UTI
9.6%
5.7%
ESRT
Higher net margin
UTI
UTI
4.2% more per $
UTI
5.8%
1.6%
ESRT
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
0.2%
ESRT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ESRT
ESRT
UTI
UTI
Revenue
$190.3M
$220.8M
Net Profit
$3.0M
$12.8M
Gross Margin
Operating Margin
15.5%
7.1%
Net Margin
1.6%
5.8%
Revenue YoY
5.7%
9.6%
Net Profit YoY
-73.7%
-42.1%
EPS (diluted)
$0.20
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESRT
ESRT
UTI
UTI
Q1 26
$190.3M
Q4 25
$199.2M
$220.8M
Q3 25
$197.7M
$222.4M
Q2 25
$191.3M
$204.3M
Q1 25
$180.1M
$207.4M
Q4 24
$197.6M
$201.4M
Q3 24
$199.6M
$196.4M
Q2 24
$189.5M
$177.5M
Net Profit
ESRT
ESRT
UTI
UTI
Q1 26
$3.0M
Q4 25
$32.2M
$12.8M
Q3 25
$13.6M
$18.8M
Q2 25
$11.4M
$10.7M
Q1 25
$15.8M
$11.4M
Q4 24
$18.8M
$22.2M
Q3 24
$22.8M
$18.8M
Q2 24
$28.6M
$5.0M
Operating Margin
ESRT
ESRT
UTI
UTI
Q1 26
15.5%
Q4 25
17.8%
7.1%
Q3 25
19.9%
11.2%
Q2 25
18.4%
6.9%
Q1 25
14.3%
8.1%
Q4 24
21.7%
13.6%
Q3 24
22.7%
13.3%
Q2 24
20.8%
4.2%
Net Margin
ESRT
ESRT
UTI
UTI
Q1 26
1.6%
Q4 25
16.1%
5.8%
Q3 25
6.9%
8.4%
Q2 25
6.0%
5.2%
Q1 25
8.8%
5.5%
Q4 24
9.5%
11.0%
Q3 24
11.4%
9.6%
Q2 24
15.1%
2.8%
EPS (diluted)
ESRT
ESRT
UTI
UTI
Q1 26
$0.20
Q4 25
$0.11
$0.23
Q3 25
$0.05
$0.33
Q2 25
$0.04
$0.19
Q1 25
$0.05
$0.21
Q4 24
$0.07
$0.40
Q3 24
$0.08
$0.35
Q2 24
$0.10
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESRT
ESRT
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$68.8M
$162.8M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$1.8B
$335.9M
Total Assets
$4.4B
$834.0M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESRT
ESRT
UTI
UTI
Q1 26
$68.8M
Q4 25
$132.7M
$162.8M
Q3 25
$154.1M
$169.1M
Q2 25
$94.6M
$70.7M
Q1 25
$187.8M
$96.0M
Q4 24
$385.5M
$172.0M
Q3 24
$421.9M
$161.9M
Q2 24
$535.5M
$115.5M
Total Debt
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
ESRT
ESRT
UTI
UTI
Q1 26
$1.8B
Q4 25
$1.1B
$335.9M
Q3 25
$1.0B
$328.1M
Q2 25
$1.0B
$306.8M
Q1 25
$1.0B
$293.9M
Q4 24
$1.0B
$280.0M
Q3 24
$1.0B
$260.2M
Q2 24
$1.0B
$239.4M
Total Assets
ESRT
ESRT
UTI
UTI
Q1 26
$4.4B
Q4 25
$4.5B
$834.0M
Q3 25
$4.1B
$826.1M
Q2 25
$4.1B
$740.8M
Q1 25
$4.1B
$720.4M
Q4 24
$4.5B
$753.8M
Q3 24
$4.4B
$744.6M
Q2 24
$4.4B
$706.0M
Debt / Equity
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESRT
ESRT
UTI
UTI
Operating Cash FlowLast quarter
$3.1M
Free Cash FlowOCF − Capex
$-19.2M
FCF MarginFCF / Revenue
-8.7%
Capex IntensityCapex / Revenue
10.0%
10.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
$249.1M
$3.1M
Q3 25
$105.3M
$57.1M
Q2 25
$26.7M
$18.1M
Q1 25
$83.1M
$-789.0K
Q4 24
$260.9M
$23.0M
Q3 24
$102.8M
$67.5M
Q2 24
$37.1M
$10.0M
Free Cash Flow
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
$50.6M
$-19.2M
Q3 25
$72.8M
$40.6M
Q2 25
$-55.1M
$6.8M
Q1 25
$41.1M
$-11.7M
Q4 24
$88.0M
$19.6M
Q3 24
$-65.1M
$60.0M
Q2 24
$19.5M
$3.0M
FCF Margin
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
25.4%
-8.7%
Q3 25
36.8%
18.3%
Q2 25
-28.8%
3.4%
Q1 25
22.8%
-5.7%
Q4 24
44.5%
9.7%
Q3 24
-32.6%
30.6%
Q2 24
10.3%
1.7%
Capex Intensity
ESRT
ESRT
UTI
UTI
Q1 26
10.0%
Q4 25
99.6%
10.1%
Q3 25
16.5%
7.4%
Q2 25
42.8%
5.5%
Q1 25
23.4%
5.3%
Q4 24
87.5%
1.7%
Q3 24
84.1%
3.8%
Q2 24
9.3%
4.0%
Cash Conversion
ESRT
ESRT
UTI
UTI
Q1 26
Q4 25
7.74×
0.24×
Q3 25
7.72×
3.04×
Q2 25
2.35×
1.69×
Q1 25
5.27×
-0.07×
Q4 24
13.88×
1.04×
Q3 24
4.51×
3.58×
Q2 24
1.30×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESRT
ESRT

Rental revenue (1)$166.1M87%
Observatory revenue$18.5M10%
Other revenue and fees$4.1M2%
Lease termination fees$1.4M1%
Third-party management and other fees$277.0K0%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons